Methods of treating leukemia
CA 2465682 A1 · Owner: Jolivet, Jacques · Inventors: Jolivet, Jacques; Kantarjian, Hagop; Giles, Francis J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a novel method for treating leukemia in a host that has been previously treated with a BrcAbl tyrosine kinase inhibitor comprising administering to the host a therapeutically effective amount of a compound having the formula I: wherein B is cytosine or 5-fluorocytosine and R is selected from H, monophosphate, diphosphate triphosphate, carbonyl , substituted with. a C1-5 alkyl C1-5 alkenyl, C1-5 alkynyl, C5-10 aryl and , and wherein each. Rc is independently selected from the group comprising H C1-, 5, alkyl, C1-5 alkenyl, C1-5.alkynyl an hydroxy protecting group
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 4, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.